U.S Patent No. 7,429,391 B2
Access Business Group International LLC, Ada, MI, has been awarded a U.S. patent for a composition that reduces pigmentation in skin. It is comprised of a multiple pigmentation inhibitor that contains at least five ingredients selected from the group consisting of hexapeptide-2; a tyrosinase activity inhibitor selected from the group consisting of ascorbic acid, derivatives of ascorbic acid, salts of ascorbic acid or its derivatives, kojic acid, arctostaphylos uva ursi leaf extract, glycyrrhiza glabra extract, sanguisorba officinalis extract, scutellaria baicalensis root extract, morus alba extract, morus bombycis extract, and mixtures thereof; a competitive inhibitor of melanin polymerization selected from the group of extracts rich in cafeic acid and helianthus annus seed extract; a component that inhibits the transfer of a melanosome to a keratinocyte selected from the group consisting of a botanical extract containing lectin and a triticum vulgare germ extract; a component to alter the ratio of eumelanin to phaeomelanin consisting of a triticum vulgare germ extract; and a component to lighten the skin through exfoliation selected from the group consisting of sodium ascorbyl phosphate, calcium ascorbyl phosphate, magnesium ascorbyl phosphate, avena sativa kernel extract; a glycoprotein, and mixtures thereof. It also contains a cell protectant comprised of at least four ingredients selected from the group extracts of “solanum tuberosum extract,” an antioxidant, a sun protectant, a cell metabolism stimulant, and an inflammation inhibitor; and at least one functional ingredient penetration enhancer selected from the group consisting of a water soluble ingredient and an oil soluble ingredient.